Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 64 (1986), S. 708-712 
    ISSN: 1432-1440
    Keywords: Milrinone ; Ouabain ; Positive inotropic effect ; Myocardium
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The interactions of milrinone, ouabain and calcium on force of contraction in isolated, contracting human papillary muscle strips were measured. Milrinone (EC50, 8 × 10−5 M) increased force of contraction maximally by 2.8±0.8 mN at 5 × 10−4M; significantly less than either ouabain (1 × 10−7M; 4.8±0.5 mN increase) or calcium (15 mM; 6.2±0.6 mN increase). A submaximal, but not a maximal, inotropic effect of ouabain could be increased by the addition of milrinone; in contrast, both ouabain and calcium increased the maximal inotropic effect of milrinone by 1.7±0.2 mN and 2.7±0.3 mN, respectively. The combined inotropic effect of milrinone with either ouabain of 4.2±0.3 mN or calcium of 5.6±0.4 mN was not different from that with calcium or ouabain alone. We conclude that further positive inotropic effects should be expected when digitalis is given to patients with congestive heart failure who are already optimally treated with milrinone.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 64 (1986), S. 786-792 
    ISSN: 1432-1440
    Keywords: Erythrocyte ; Heart muscle ; Receptor regulation ; (Na++K+)-ATPase
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The assumption that the red blood cell can be used as a model for ouabain receptor regulation in heart muscle has been tested using isolated tissues from humans, guinea pigs, and chickens. The following results were obtained: 1. The affinity of the ouabain receptor was similar in both human erythrocytes and right atrial appendage, but the density of binding sites was much lower on the erythrocytes. There was no correlation between the binding capacity in both tissues. 2. Ouabain receptor occupation was closely correlated with inhibition of Na+/K+-transport in human erythrocytes and chick heart nonmuscle cells in culture. In contrast, in chick heart muscle cells, an occupation of 40% of the receptors decreased the Na+/K+-transport rate by only 10%. 3. In hypokalemia, the ouabain binding capacity was increased in human and guinea pig erythrocytes but not in guinea pig heart muscle. Such increases were seen in chick heart nonmuscle cells in moderate hypokalemia but in heart muscle cells only after severe hypokalemia. Incubation of chick heart muscle cells in toxic but not in “therapeutic” ouabain concentrations increased the number of ouabain receptors. Increases in receptor number attenuated the positive inotropic and toxic actions of ouabain. These variations between ouabain receptor regulation in red blood cells and heart muscle of several species may be attributable to the lack of a “sodium pump reserve” in erythrocytes and heart nonmuscle cells. Such variations indicate that the human erythrocyte is not a suitable model for the ouabain receptor in the human heart.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-1440
    Keywords: Na+-Li+ Countertransport ; Electrolytes ; Erythrocytes ; Essential hypertension ; Antihypertensive treatment
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The effect of antihypertensive treatment with 6–12 mg of the loop diuretic piretanide over 12 weeks on Na+-Li+ countertransport, and on extra- and intracellular electrolyte composition was studied in 10 previously untreated patients with essential hypertension. These data were compared with 10 sex- and age-matched controls. Blood pressure fell from 180±18.3/110.5±9.8 to 154.7±9.7/92.5±10.9 mmHg during treatment. Na+-Li+ countertransport was significantly higher in hypertensives (0.36±0.13 mmol×l rbc −1 ×h−1) compared with controls (0.25±0.05;P〈0.05). Na+-Li+ countertransport and intracellular electrolyte composition remained unchanged whereas the extracellular potassium concentration fell from 4.28±0.51 to 3.98±0.36 mmol/l (P〈0.05). No increase in the intracellular Na+ content as compared with normotensive controls was found. It is concluded that the intracellular Na+ concentration is not a marker for essential hypertension. The Na+-Li+ countertransport does not seem to be directly related to elevated blood pressure but seems to be a general marker for diseases associated with an increased risk for the development of hypertension.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 63 (1985), S. 1117-1123 
    ISSN: 1432-1440
    Keywords: Dopamine ; Levodopa ; Positive inotropic effect ; Human heart
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The direct positive inotropic effects of dopamine and its precursor, levodopa, were measured using isolated, contracting human papillary muscle strips taken from patients during mitral valve replacement. Levodopa did not produce any positive inotropic effect at concentrations up to 3×10−3 M. The positive inotropic effects of dopamine were observed at concentrations above 1×10−5 M with the maximal effect at 3×10−3 M — concentrations higher than those observed in therapy. This inotropic effect was reduced by the β1 antagonist, 1-practolol (1×10−6 M); the β2 antagonist, ICI 118,551 HCl (1×10−6 M); the dopamine antagonist, haloperidol (3×10−6 M); the neuronal uptake inhibitor, cocaine (3×10−5 M), but not by the α1, prazosin (1×10−7 M). This indicates that dopamine exerts its positive inotropic effects on human heart muscle mainly through release of noradrenaline, together with possible interactions at β-and dopamine-receptors. The maximal inotropic effect of dopamine was about 50% that of calcium (15 mM, 6.2±0.7 mN) or ouabain (1×10−7 M, 5.0±0.8 mN) when measured in the same muscle strips, possibly due to the reduced cardiac noradrenaline content together with the reduced β-receptor number in congestive heart failure. This concentration of ouabain (1×10−7 M) gave almost maximal inotropy without marked toxicity; when dopamine was then added, only toxicity developed without any further increases in force of contraction. Any haemodynamic benefits of dopamine therapy in optimally digitalis-treated patients are probably due to other cardiovascular effects such as vasodilatation.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 63 (1985), S. 1253-1264 
    ISSN: 1432-1440
    Keywords: Cardiac glycosides ; Tolerance ; Heart cells
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary In cultured heart muscle cells from 10–13 day-old chicken embryos, the effects of acute (4 h) and chronic (3 days) exposure of the cells to varying concentrations of ouabain have been studied. In these cells, the cardiac glycoside ouabain binds to a specific cardiac glycoside receptor (KD=4 × 10−7 M; 750,000 receptors/cell). Binding to this receptor results in inhibition of active Na+/K+-transport [EC50 for active (86Rb+ + K+)-influx=4 × 10−6 M], and in an increase in beating velocity (“positive inotropic effect”;; EC50=4 × 10−7 M); toxic signs (arrhythmias) appear at concentrations ≥ 6 × 10−7 M. During exposure of the cells to 3 × 10−6 M ouabain for 3 days, tolerance develops with respect to both the positive inotropic and the toxic effect. The mechanism underlying this tolerance is identified as an increase in the number of active sodium pump molecules per cell, while the binding properties of the cardiac glycoside receptor remain unchanged. The development of cardiac glycoside tolerance is only observed in the presence of severe impairment of Na+/K+-homeostasis, due to cardiac glycoside-induced inhibition of active Na+/K+-transport. This, however, only occurs in the presence of toxic (receptor occupation ≥ 60%), but not in the presence of positive inotropic, non-toxic (receptor occupation 20–60%), ouabain concentrations. We conclude that the development of cardiac glycoside tolerance during long-term treatment in patients with heart failure should not occur with submaximal dose regimens, when toxic signs (arrhythmias) are absent.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 64 (1986), S. 938-938 
    ISSN: 1432-1440
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 66 (1988), S. 1-6 
    ISSN: 1432-1440
    Keywords: Human heart ; Positive inotropism ; β-Adrenoceptors ; Phosphodiesterase inhibitors
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary This review analyses the present knowledge on differences in human and animal heart preparations in respect to positive inotropic stimulation. The pharmacological effects of new positive inotropic drugs usually are evaluated in cardiac preparations from healthy and young animals. Human myocardium, especially from patients with heart failure has, however, distinctly different properties in respect to the positive inotropic effectiveness of several agents. This fact prohibits the extrapolation of results of experiments in laboratory animals to the diseased human heart. The partial ineffectiveness of several established positive intropic substances in papillary muscles from failing human hearts indicates a membrane defect not present in healthy animal myocardium.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 65 (1987), S. 948-948 
    ISSN: 1432-1440
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    ISSN: 1432-1440
    Keywords: Antikaliuretic diuretics ; Positive inotropic effects ; Antiarrhythmic action ; Receptor for cardiac glycosides ; (Na++K+)-ATPase ; Antikaliuretische Diuretika ; Positiv inotroper Effekt ; Antiarrhythmische Wirkung ; Herzglykosidrezeptor ; (Na++ K+)-ATPase
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Die in letzter Zeit mehrfach berichteten direkten myokardialen Wirkungen der antikaliuretischen Diuretika Kanrenoat-Kalium und Triamteren wurden an herzkranken Patienten der Intensivstation überprüft. Außerdem wurden die Membraneffekte dieser Pharmaka auf die [3H]g-Strophanthinbindung an den Herzglykosidrezeptor und die (Na++K+)-ATPase-Aktivität isolierter menschlicher Herzmuskelzellmembranen gemessen, um die ihren Wirkungen zugrunde liegenden biochemischen Vorgänge aufzuklären. Mit Hilfe von Einschwemmkathetern (Swan-Ganz) in die A. pulmonalis und der Thermodilutionsmethode wurde das Herzminutenvolumen bei 16 Patienten gemessen. Triamteren (100–2000 mg p.o.) sowie Kanrenoat-Kalium in einer Dosierung von 200–1000 mg i.v. riefen keine signifikanten Änderungen der Meßwerte hervor. Nur nach der wiederholten intravenösen Applikation von Kanrenoat-Kalium (200 mg und nach 60 min 400 mg) konnte bei 7 Patienten ein Anstieg des Herzminutenvolumens um 11% (p〈0,05) gemessen werden. Bei 14 Patienten mit ventrikulärer Extrasystolie in Koinzidenz mit Digoxinkonzentrationen im Serum von 1,6–4,4 ng/ml war lediglich in 2 Fällen ein antiarrhythmischer Effekt durch Gabe von Kanrenoat-Kalium (200–400 mg i.v.) zu verzeichnen. Wegen seiner strukturellen Ähnlichkeit mit Herzglykosiden und seiner positiv inotropen Wirksamkeit liegt es nahe anzunehmen, daß Kanrenoat-Kalium wie Herzglykoside eine Bindung mit dem Herzglykosidrezeptor eingeht und wie diese die (Na++K+)-ATPase hemmt. Tatsächlich verdrängt Kanrenon, der Metabolit des Kanrenoat-Kalium, radioaktiv markiertes g-Strophanthin aus der Rezeptorbindung und hemmt die (Na++K+)-ATPase in den Konzentrationen, die auch in vivo nach therapeutischer Applikation gemessen worden sind. Bei Triamteren treten diese Wirkungen erst bei extrem hohen Konzentrationen auf, was auf unspezifische Effekte schließen läßt. Da Kanrenon an der Zellmembran Herzglykosidähnliche Eigenschaften hat, sind Digitalis-antagonistische (antiarrhythmische) Wirkungen nicht zu erwarten, während der positiv inotrope Effekt erklärlich ist.
    Notes: Summary Recently direct myocardial effects of antikaliuretic diuretics with respect to contractility parameters and prevention of digitalis-induced arrhythmias were published. In order to test the value of these reports we measured the effect of potassium-canrenoate and triamterene on cardiac output and on digitalis-induced arrhythmias in patients during diagnostic and therapeutic flow directed right heart catheterization (Swan-Ganz) in our intensive care unit. In addition the influence of these drugs on (Na++K+)-ATPase and on [3H]g-strophanthin binding to human cardiac cell membranes was investigated to gain information on the mechanism of their action. Triamterene (100–200 mg p.o.) was without any effect on cardiac output, the same was found true for potassium-canrenoate given in a single dose (200–1000 mg intravenously). However, when applied in two doses (200 mg i.v. and 60 min later 400 mg i.v.), potassium-canrenoate increased cardiac output by 11 per cent (p〈0.05). Only in 2 out of 14 patients potassium-canrenoate (200–400 mg i.v.) suppressed digitalis-induced ventricular ectopic beats. Canrenone, the active metabolite of potassium-canrenoate displaces [3H]g-strophanthin from its binding sites in human cardiac cell membranes and inhibits (Na++K+)-ATPase activity. These in vitro effects were measured at the same concentrations as found in vivo after “therapeutical” doses. The effects of triamterene in this respect were found only in extremely high concentrations. Our results imply that canrenone has cardiac glycoside-like effects in human cardiac cell membranes.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 57 (1979), S. 699-700 
    ISSN: 1432-1440
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...